Daniela Califano

3.7k citations

62 papers · 2.6k indexed · 1 hit paper · h-index 29

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 5%
- Cancer-related Molecular Pathways

Papers in

Reproductive Medicine 11
- Ovarian cancer diagnosis and treatment 11
Oncology 29
- Cancer-related Molecular Pathways 11
- PARP inhibition in cancer therapy 7
- Cancer Immunotherapy and Biomarkers 5

Co-authors: Alfredo Fusco Giuseppe Viglietto Gennaro Chiappetta Maria Letizia Motti Massimo Santoro Giovanni Santelli Amelia D’Alessio Paola Bruni
Journals: Cancer Treatment Reviews (3 papers)Journal of Biological Chemistry (3 papers)Oncotarget (3 papers)Journal of Medicinal Chemistry (3 papers)Journal of Cellular Physiology (2 papers)
Partner nations: Italy United States France

In The Last Decade

Daniela Califano

60 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer 2002 · 562 citations

Peers

Countries citing papers authored by Daniela Califano

Since Specialization

Citations

This map shows the geographic impact of Daniela Califano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Califano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Califano more than expected).

Fields of papers citing papers by Daniela Califano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Califano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Califano. The network helps show where Daniela Califano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniela Califano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniela Califano Line = papers co-authored together Daniela Califano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study Clinical and Translational Medicine ·Kavita H. Gudadhe, Vincenzo Canzonieri, Rossella De Cecio, Laura Arenare, Domenica Lorusso, Sabrina Chiara Cecere, Eliana Pivetta, Daniela Russo, Annabella Di Mauro, Grazia Artioli, Anna Spina, Sathiyabama Dhinakaran, Daniela Califano, Saverio Cinieri, Giosuè Scognamiglio, Leonardo Henrique da Silva, Paolo Chiodini, Federica Perrone, Sandro Pignata, Gustavo Baldassarre	2025	1
2	Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer Current Oncology ·I Pelliccioli, Michele Bartoletti, Pathik Pathak, Serena Corsetti, E. A. B., Shiyi Xuan, 容鎰李, Sun Jie, Miki Taki, Michael Douglas Souza Evangelista, I Wayan Angga Wijaya Kusuma, Daniele Marra, Sara Cecco, Paolo Baldo, Sandro Pignata, Daniela Califano, Vincenzo Canzonieri, Antonino Ditto, Fabio Puglisi	2025	0
3	Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay International Journal of Molecular Sciences ·Giovanni Luca Scaglione, Sandro Pignata, 郭沛源, Carmela Paolillo, Daniela Califano, Giuseppa Scandurra, Hong Huan Zhang, Francesca Di Gaudio, Basilio Pecorino, Liliana Mereu, Paolo Scollo, Ettore Capoluongo	2023	4
4	The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma Journal of Experimental & Clinical Cancer Research ·Francesco Morra, Francesco Merolla, Giovanna Damia, Francesca Ricci, Silvia Varricchio, Gennaro Ilardi, Laura Arenare, Daniela Califano, Virginia Napolitano, Robert Fruscio, Rosa Marina Melillo, Luca Palazzo, Angela Celetti	2022	9
5	Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer Frontiers in Immunology ·Anna Passarelli, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Sabrina Rossetti, Rosa Tambaro, Jole Ventriglia, Federica Gherardi, Lei Wu, Czapla-Masztafiak Joanna, H. K. Vivanco, Michele Bartoletti, Giosuè Scognamiglio, Daniela Califano, Sandro Pignata	2022	18
6	Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience Cells ·Daniela Califano, Daniela Russo, Giosuè Scognamiglio, Simona Losito, Anna Spina, Anna Maria Bello, Jess Miklosko, S. Chugunnaya, Rossella De Cecio, Simona Bevilacqua, Piera Gargiulo, Edoardo Marchesi, Silvana Canevari, Francesco Perrone, Gennaro Daniele, Loris De Cecco, Delia Mezzanzanica, Sandro Pignata	2020	2
7	Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives Cancer Treatment Reviews ·Jole Ventriglia, 田端道彦, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Rosa Tambaro, Daniela Califano, Simona Losito, Giosuè Scognamiglio, Sergio Venanzio Setola, Laura Arenare, Sandro Pignata, Chiara Della Pepa	2017	119
8	CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation EMBO Molecular Medicine ·Alessandra Dall’Acqua, Maura Sonego, J. Torres Torremocha, Ilenia Pellarin, Vincenzo Canzonieri, Sara D’Andrea, А А Бобров, Roberto Sorio, Giorgio Giorda, Daniela Califano, Marina Bagnoli, Loredana Militello, Delia Mezzanzanica, Gennaro Chiappetta, Joshua Armenia, Barbara Belletti, Mónica Schiappacassi, Gustavo Baldassarre	2017	67
9	Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy Cancer Immunology Research ·Anna Maria Trotta, Alessandro Ottaiano, Carmela Romano, Guglielmo Nasti, Anna Nappi, Chiara De Divitiis, Maria Napolitano, Serena Zanotta, Rossana Casaretti, Crescenzo D’Alterio, Antonio Avallone, Daniela Califano, Rosario Vincenzo Iaffaioli, Stefania Scala	2016	62
10	miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting The Journal of Clinical Endocrinology & Metabolism ·Marianna Colamaio, Eleonora Borbone, Lucia Russo, Mimma Bianco, Antonella Federico, Daniela Califano, Gennaro Chiappetta, Pierlorenzo Pallante, Giancarlo Troncone, Sabrina Battista, Alfredo Fusco	2011	48
11	BAG3 Down-Modulation Reduces Anaplastic Thyroid Tumor Growth by Enhancing Proteasome-Mediated Degradation of BRAF Protein The Journal of Clinical Endocrinology & Metabolism ·Gennaro Chiappetta, Anna Basile, Claudio Arra, Daniela Califano, Rosa Pasquinelli, Antônio Barbieri, Veronica De Simone, Domenica Rea, Aldo Giudice, Luciano Pezzullo, Vincenzo De Laurenzi, Gerardo Botti, Simona Losito, Козляков Алексей Викторович, Maria Caterina Turco	2011	28
12	HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias European Journal of Cancer ·Gennaro Chiappetta, Angelo Ferraro, Emilia Vuttariello, Mario Monaco, S. Chugunnaya, Veronica De Simone, Daniela Califano, Pierlorenzo Pallante, Gerardo Botti, Luciano Pezzullo, Giovanna Maria Pierantoni, Massimo Santoro, Alfredo Fusco	2008	59
13	Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer Endocrine Related Cancer ·Gennaro Chiappetta, Carmela De Marco, Li Xin Shen, Daniela Califano, D. C. Arne, Donatella Malanga, Marianna Scrima, Cristina Montero‐Conde, Letizia Cito, Mario Monaco, Maria Letizia Motti, Rosa Pasquinelli, Valter Agosti, Mercedes Robledo, Alfredo Fusco, Giuseppe Viglietto	2007	31
14	p27Kip1 is expressed in proliferating cells in its form phosphorylated on threonine 187 BMC Clinical Pathology ·Giancarlo Troncone, Juan Carlos Martı́nez, Antonino Iaccarino, Pio Zeppa, Alessia Caleo, Maria Russo, Ilenia Migliaccio, Maria Letizia Motti, Daniela Califano, Emiliano A. Palmieri, Lucio Palombini	2005	5
15	Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK Journal of Biological Chemistry ·Seymen Avci, Amelia D’Alessio, Daniela Califano, Gaetano Calı̀, Claudia Rizzo, Lucio Nitsch, Giovanni Santelli, Vittorio de Franciscis	2000	35
16	Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells Journal of Biological Chemistry ·Daniela Califano, Claudia Rizzo, Amelia D’Alessio, Seymen Avci, Gaetano Calı̀, Juliane de Melo Rodrigues, Giovanni Santelli, Giancarlo Vecchio, Vittorio de Franciscis	2000	49
17	Thymosin β-10 Gene Overexpression Is a General Event in Human Carcinogenesis American Journal Of Pathology ·Giovanni Santelli, Daniela Califano, Gennaro Chiappetta, Maria Teresa Vento, Juliane de Melo Rodrigues, Fulvio Zullo, Francesco Trapasso, Giuseppe Viglietto, Alfredo Fusco	1999	88
18	Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization Oncogene ·Giuseppe Viglietto, Annunciata Romano, Henrike Purtik, Gennaro Chiappetta, Iole Paoletti, Daniela Califano, Rolando Zapata, Anita Helena Schleseneer, Paola Bruni, J. M. Yang, Alfredo Fusco, M. Graziella Persico	1997	91
19	Low frequency of p53 mutations in human thyroid tumors; p53 and Ras mutation in two out of fifty-six thyroid tumours European Journal of Endocrinology ·Domenico Salvatore, Angela Celetti, Nicole Fabien, C. Paulin, Marialuisa Martelli, Patrick K. Ober, Daniela Califano, C Monaco, Giuseppe Viglietto, Massimo Santoro, Alfredo Fusco	1996	32
20	Thyroid Specific Expression of the Ki-ras Oncogene in Transgenic Mice Advances in experimental medicine and biology ·Giovanni Santelli, Vittorio de Franciscis, Gennaro Chiappetta, Amelia D’Alessio, Daniela Califano, Alba Mineo, C Monaco, Giancarlo Vecchio	1993	7

About Daniela Califano

Daniela Califano is a scholar working on Reproductive Medicine, Oncology, Cell Biology, Toxicology and Cancer Research, having authored 62 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ovarian cancer diagnosis and treatment (11 papers), PARP inhibition in cancer therapy (7 papers), Microtubule and mitosis dynamics (6 papers), Cellular Mechanics and Interactions (6 papers), Thyroid Cancer Diagnosis and Treatment (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (577 citations), Oncology (964 citations), Molecular Biology (1.6k citations), Reproductive Medicine (174 citations) and Endocrinology, Diabetes and Metabolism (289 citations). Daniela Califano has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Alfredo Fusco, Giuseppe Viglietto, Gennaro Chiappetta, Maria Letizia Motti, Massimo Santoro, Giovanni Santelli, Amelia D’Alessio, Paola Bruni, Rosa Marina Melillo and Alfonso Bellacosa. Their work appears in journals such as Cancer Treatment Reviews, Journal of Biological Chemistry, Oncotarget, Journal of Medicinal Chemistry and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact